Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 9, 2024Frontiers in OncologyOpen Access

Effect of high-dose polymeric nanoparticle micellar paclitaxel on improved progression-free survival in patients with optimally resected stage III or IV high-grade carcinoma of the ovary: a prospective cohort study with historical controls

View Full Paper
Ask AI
Bookmark
Share

Authors

SPSoo Jin ParkSamsung Medical CenterJSJoo‐Hyuk SonTKTae‐Wook KongAjou University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Park et al. (2024) studied this question.

synapsesocial.com/papers/68e7a413b6db64358770c12fhttps://doi.org/10.3389/fonc.2024.1203129
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer2018 · 118 citations
  2. 2Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer2019 · 2,326 citations
  3. 3Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian Cancer1996 · 2,876 citations
  4. 4An open-label, multicenter, phase I trial of a cremophor-free, polymeric micelle formulation of paclitaxel combined with carboplatin as a first-line treatment for advanced ovarian cancer: a Korean Gynecologic Oncology Group study (KGOG-3016)2016 · 27 citations
  5. 5Synthesis and evaluation of some water-soluble prodrugs and derivatives of taxol with antitumor activity1992 · 250 citations